EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology

Javier Alejandro Delgado-Nungaray, Dulce Alitzel Pérez-Ponce, Luis Joel Figueroa-Yáñez, Eire Reynaga-Delgado, Mario Alberto García-Ramírez, Orfil Gonzalez-Reynoso

Journal of Genome Biotechnology and Genetics · 2026-06-24 · 1 (2) · 10

DOI: 10.3390/jgbg1020010 ↗

At a glance

Journal article in Journal of Genome Biotechnology and Genetics, published online on 2026-06-24. Written by Javier Alejandro Delgado-Nungaray and 5 co-authors. 135 references. The full text is freely available (open access, CC BY 4.0). Funded by: SECIHTI.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

CRISPR-Cas9 has transformed microbial biotechnology by enabling precise genome modifications; however, achieving high editing efficiency remains a challenge due to multiple determinants, including on-target specificity, off-target events, PAM sequence, sgRNA scaffold composition, and RNA secondary structure. Our review foresees how artificial intelligence (AI) can address those challenges by enabling automated identification as well as highly active guide RNA (gRNA) optimisation. We highlight the influence of a data-driven training strategy that is focused on high-quality, diverse, and accurately labelled microbial datasets—mainly, given the limitations of models derived from mammalian systems that are not directly transferable to microbial organisms. Moreover, we discuss the key role of FAIR (Findable, Accessible, Interoperable, and Reusable) data principles and centralised, curated CRISPR-Cas databases as foundational elements for developing robust and predictive frameworks. Emerging directions are also explored, including generative AI approaches capable of supporting automated experimental planning. By considering the potential dual use of such technologies, the review further addresses bioethical considerations and regulatory frameworks necessary to ensure responsible genome engineering as a milestone, as well as the implementation of safeguards against misuse, particularly in pathogenic microorganisms. Furthermore, the convergence of standardised experimental data, specialised microbial datasets, and advanced AI architectures is paving the way to transform microbial biotechnology by accelerating metabolic engineering and synthetic biology applications.

Funding

  • SECIHTI

Cite

APA

Delgado-Nungaray, J. A., Pérez-Ponce, D. A., Figueroa-Yáñez, L. J., Reynaga-Delgado, E., García-Ramírez, M. A., & Gonzalez-Reynoso, O. (2026). Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology. Journal of Genome Biotechnology and Genetics, 1(2), 10. https://doi.org/10.3390/jgbg1020010

Vancouver

Delgado-Nungaray JA, Pérez-Ponce DA, Figueroa-Yáñez LJ, Reynaga-Delgado E, García-Ramírez MA, Gonzalez-Reynoso O. Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology. Journal of Genome Biotechnology and Genetics. 2026;1(2):10. doi:10.3390/jgbg1020010

BibTeX
@article{DelgadoNungaray2026,
  author = {Delgado-Nungaray, Javier Alejandro and Pérez-Ponce, Dulce Alitzel and Figueroa-Yáñez, Luis Joel and Reynaga-Delgado, Eire and García-Ramírez, Mario Alberto and Gonzalez-Reynoso, Orfil},
  title = {Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology},
  journal = {Journal of Genome Biotechnology and Genetics},
  year = {2026},
  volume = {1},
  number = {2},
  pages = {10},
  doi = {10.3390/jgbg1020010}
}
Start for free →